Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, July 18, 2017

Public edition | newswise.com

Newswise Cancer Research Wire for 18-Jul-2017
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



New Study Finds That Lymph Node Removal Isn’t Necessary For All Melanoma Patients

Many patients with melanoma need a sentinel-lymph-node biopsy to determine if cancer cells have spread there, but a positive finding doesn’t mean all the lymph nodes in the area must be removed, according to a new international study.

– Intermountain Medical Center


New Way to Enlarge Tissues Gives Pathologists a Closer Look at Cells

Investigators from Beth Israel Deaconess Medical Center and the Massachusetts Institute of Technology have developed and tested an innovative, reliable means of analyzing pre-cancerous breast lesions diagnosing certain kidney diseases and using only ...

– Beth Israel Deaconess Medical Center

W911NF1510548; 1R01GM104948; 1DP1NS087724; 1R01EY023173; 1U01MH106011; 1R01MH110932; Ul1TR001102

Embargo expired on 17-Jul-2017 at 11:00 ET


CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial

Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric antigen receptor (CAR) T-cell immunotherapy. The res...

– Fred Hutchinson Cancer Research Center

Embargo expired on 17-Jul-2017 at 16:00 ET


Modern Disease Transmission, Teens and Vaccines, Tobacco Control, and More in the Public Health News Source

The latest research, experts and features in Public Health in the Public Health News Source

– Newswise


A Swell Diagnostic Method

Ludwig researchers show how a method that physically expands tissues can improve early breast cancer diagnostics and extend the capabilities of ordinary pathology labs

– Ludwig Cancer Research

Nature Biotechnology, Jul-2017


Radiation Therapy Prior to Surgery Reduces the Risk of Secondary Tumors in Early-Stage Breast Cancer Patients

Moffitt researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery or after surgery. Their study found that patients who have neoadjuvant radiation therapy ha...

– Moffitt Cancer Center


T-cells Lacking HDAC11 Enzyme Perform More Effectively in Destroying Cancer Cells

A team of researchers at the GW Cancer Center has identified a role for the HDAC11 enzyme in the regulation of T-cell function. The team found that HDAC11 should be treated as an immunotherapeutic target.

– George Washington University

Blood


Comparing Algorithms That Search for Cancer Mutations

Scientists team up to evaluate the tools used to probe the cancer genome

– Sanford Burnham Prebys Medical Discovery Institute


Abraxis Expands Its Magnetic Beads Offering for Molecular Biology and Sample Prep Applications

Abraxis, Inc., announces expansion of its AbraMag magnetic beads line for molecular biology, biochemistry and sample prep applications, with the addition of mRNA purification beads and kit.

– 69th AACC Annual Scientific Meeting Press Program


Nipple-Sparing Mastectomy Has Low Rate of Breast Cancer Recurrence

Women with breast cancer who undergo nipple-sparing mastectomy (NSM) have a low rate of the cancer returning within the first five years, when most recurrences in the breast are diagnosed, findings of a single-center study show.

– American College of Surgeons (ACS)


FDA Gives A Nod To "Paradigm Shifting" Cancer Treatment

A key committee for the U.S. Food and Drug Administration issued a first-of-its-kind recommendation this week, unanimously signing off on an experimental cancer treatment

– Yale Cancer Center


Bacteria Actively Drive Development of Colorectal Cancer

Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.

– Texas A&M University

PLOS Pathogens, July-2017; CA016672; The study was supported by funds from the Hamill Foundation and Texas A&M Health Science Center; The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment...


Genetically Enhanced, Cord-Blood Derived Immune Cells Strike B-Cell Cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer ...

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 13-Jul-2017 at 03:45 ET


Appropriate Distress Screening and Follow Up Leads to Fewer ER Visits and Hospitalizations in Patients with Cancer, Study Finds

As published in JNCCN, a University of Michigan Comprehensive Cancer Center study found that adherence to distress screening protocols set by the Commission on Cancer could lead to 18% fewer ER visits and 19% fewer hospitalizations.

– National Comprehensive Cancer Network® (NCCN®)


Cancer Cells Force Normal Cells to Mimic Viruses to Help Tumors Spread, Resist Treatment

In a study that could explain why some breast cancers are more aggressive than others, researchers say they now understand how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread. The virus mi...

– Perelman School of Medicine at the University of Pennsylvania

F31CA189707; R01GM111959; 2-P30-CA-016520-35


Diet Rich in Tomatoes Cuts Skin Cancer in Half in Mice

Daily tomato consumption appeared to cut the development of skin cancer tumors by half in a mouse study at The Ohio State University.

– Ohio State University

Scientific Reports


Big-Data Analysis Points Toward New Drug Discovery Method

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses. ...

– UCSF Helen Diller Family Comprehensive Cancer Center

Nature Communications


Surgery for Early Prostate Cancer May Not Save Lives

A major 20-year study provides further evidence that prostate cancer surgery offers negligible benefits to many men with early-stage disease. In such men, who account for most cases of newly diagnosed prostate cancer, surgery did not prolong life and...

– Washington University in St. Louis

The New England Journal of Medicine, July 13, 2017


Tumor-Targeting Drug Shows Potential for Treating Bone Cancer Patients

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic...

– University of Texas M. D. Anderson Cancer Center


Risk-Reducing Mastectomy Questioned for BRCA Mutation Carriers with Prior Ovarian Cancer

For the subset of women with BRCA mutations who have already had ovarian cancer, risk-reducing mastectomy might not be worth the price tag. New research from the Duke Cancer Institute finds that for many women in this unique group, prophylactic maste...

– Duke Health

Annals of Surgical Oncology


Skin in the Game: Dermatology’s Role in Antibiotic Stewardship

While discussions on stewardship are often focused on fighting infection among the sickest patients, those aren’t the only people taking these drugs. Data from the CDC shows the average dermatology provider wrote 669 antibiotic prescriptions in 201...

– Perelman School of Medicine at the University of Pennsylvania


Policy and Public Affairs


ASTRO Updates Insurance Coverage Recommendations for Proton Therapy

The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer. The updated Proton Beam Therapy Model Policy provides guidance to...

– American Society for Radiation Oncology (ASTRO)


Announcements


ACR Works With ASTRO and AAPM to Update Radiation Oncology and Medical Physics Guidance

The American College of Radiology (ACR) collaborated with professional medical societies to update guidance to promote safe and effective diagnostic and therapeutic radiology use.

– American College of Radiology (ACR)


San Diego County Volunteer Selected as 2017 ASTRO Survivor Circle Award Winner

The winner of the American Society for Radiation Oncology’s (ASTRO’s) 2017 Survivor Circle Award is many things—a former pro baseball player, a retired UPS driver, a family man and, yes, a current cancer patient.

– American Society for Radiation Oncology (ASTRO)


UNM Cancer Center Doctor Receives National Cancer Institute Award

Ursa Brown-Glaberman, MD, received the National Cancer Institute’s Cancer Clinical Investigator Team Leadership Award. The NCI award is given to outstanding cancer clinical investigators. Cancer clinical investigators conduct clinical trials to dis...

– University of New Mexico Comprehensive Cancer Center


First Michigan Proton Center Begins Treating Cancer Patients

Proton therapy is a high-tech alternative to X-ray radiation. It offers greater precision to destroy cancerous cells, sparing adjacent healthy tissue with fewer side effects. Proton therapy uses atomic particles, traveling up to two-thirds the speed ...

– Beaumont Health

Embargo expired on 13-Jul-2017 at 11:15 ET


New Chief Nursing Officer Named at Rutgers Cancer Institute of New Jersey

Janet Gordils-Perez, DNP, RN, ANP-BC, AOCNP, from Plainsboro Township, has been named Chief Nursing Officer at Rutgers Cancer Institute of New Jersey. She was recently promoted from her position as Director of Oncology Nursing. Dr. Gordils-Perez came...

– Rutgers Cancer Institute of New Jersey


Thomas Flaig, MD, Named Chair of NCCN Bladder Cancer Panel

University of Colorado Cancer Center's Thomas Flaig, MD, has been named chair of the NCCN Clinical Practice Guidelines in Oncology Panel for Bladder Cancer, a group of 34 multidisciplinary bladder experts from NCCN Member Institutions that will influ...

– University of Colorado Cancer Center


Marketplace


ALCEA ADVISORS, the Reference Partner for Oncology Startups in Europe, Expands Its Leadership Team with Dr. Jacques-Pierre Moreau and Dr. Nuno Arantes-Oliveira Joining as Venture Partners

ALCEA ADVISORS adds world class entrepreneurial and translational talent to continue to deliver on its vision to back the boldest entrepreneurs in the oncology space in Europe

– ALCEA ADVISORS

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

  Newswise

 Washington University in St. Louis

 Duke Health

 University of Texas M. D. Anderson Cancer Center

 George Washington University

 The Rockefeller University Press

 Beaumont Health


Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us